Preveon adefovir dipivoxil: Phase III

Data from 5 patients enrolled in an expanded access program (Study GS 423) suggested that a regimen without a protease inhibitor that included Glaxo Wellcome's Ziagen abacavir and DuPont's Sustiva efavirenz, reduced viral load. These patients had failed other anti-retroviral drugs.

Side effects of Preveon have included changes in markers of kidney and liver function, and gastrointestinal effects. ...